Clinical evaluation in adult human revealed the biosimilarity of recombinant Erythropoietin GBPD002 with Eprex®. (2023). Archives of Clinical and Biomedical Research, 7(4), 459-474. https://fortunejournals.org/ojs/index.php/acbr/article/view/15029